
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Utah Medical Products Inc (UTMD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: UTMD (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -45.22% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 183.78M USD | Price to earnings Ratio 14.14 | 1Y Target Price - |
Price to earnings Ratio 14.14 | 1Y Target Price - | ||
Volume (30-day avg) 17626 | Beta 0.06 | 52 Weeks Range 55.80 - 76.21 | Updated Date 04/1/2025 |
52 Weeks Range 55.80 - 76.21 | Updated Date 04/1/2025 | ||
Dividends yield (FY) 2.17% | Basic EPS (TTM) 3.96 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 33.92% | Operating Margin (TTM) 35.67% |
Management Effectiveness
Return on Assets (TTM) 7.62% | Return on Equity (TTM) 11.29% |
Valuation
Trailing PE 14.14 | Forward PE - | Enterprise Value 101143696 | Price to Sales(TTM) 4.57 |
Enterprise Value 101143696 | Price to Sales(TTM) 4.57 | ||
Enterprise Value to Revenue 2.56 | Enterprise Value to EBITDA 6.36 | Shares Outstanding 3281820 | Shares Floating 2826694 |
Shares Outstanding 3281820 | Shares Floating 2826694 | ||
Percent Insiders 7.12 | Percent Institutions 72.87 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Utah Medical Products Inc

Company Overview
History and Background
Utah Medical Products, Inc. was founded in 1978. It designs, develops, manufactures, and markets a broad range of disposable and reusable specialty medical devices, primarily for the care of women and their babies.
Core Business Areas
- Labor & Delivery: Products designed to improve the safety and efficiency of childbirth, including fetal monitoring catheters and vacuum delivery systems.
- Electrosurgical Products & Accessories: Products include electrosurgical loops and electrodes used in LEEP (Loop Electrosurgical Excision Procedure) for the treatment of cervical dysplasia.
- Other Specialty Products: Encompasses various products such as those used for neonatal care, including umbilical vessel catheters and pressure monitoring devices.
Leadership and Structure
Kevin Cornwell is the CEO. The company has a board of directors and operates through distinct departments focusing on manufacturing, sales, and research & development.
Top Products and Market Share
Key Offerings
- Fetal Monitoring Catheters: These catheters monitor the fetal heart rate and uterine contractions during labor. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Medtronic.
- Vacuum Delivery Systems: Used to assist in childbirth when complications arise. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Kiwi Medical.
- LEEP Products: Electrosurgical loops and electrodes used to treat cervical dysplasia. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Bovie Medical.
Market Dynamics
Industry Overview
The medical device industry is driven by technological advancements, an aging population, and increasing healthcare spending. It is highly regulated and competitive.
Positioning
Utah Medical Products focuses on niche markets within women's and infant's health, emphasizing product innovation and high-quality manufacturing, leading to a strong reputation for quality and safety. Their competitive advantage is their specialization and focus on specific medical needs.
Total Addressable Market (TAM)
The global medical device market is in the billions of dollars. Utah Medical Products focuses on niche markets; their TAM is a subset of the overall medical device market, particularly within obstetrics and gynecology. The company's market share is relatively small compared to the overall medical device TAM, but strategically positioned within its specific segments.
Upturn SWOT Analysis
Strengths
- Specialized product portfolio
- Strong brand reputation for quality
- Focus on niche markets
- Established distribution network
- High profit margins
Weaknesses
- Limited product diversification
- Dependence on specific market segments
- Smaller size compared to major competitors
- Vulnerability to regulatory changes
- Geographic concentration of revenue
Opportunities
- Expanding into new geographic markets
- Developing innovative products
- Acquiring complementary businesses
- Leveraging technological advancements
- Increasing demand for minimally invasive procedures
Threats
- Increased competition
- Product liability claims
- Healthcare cost containment pressures
- Changing regulatory landscape
- Economic downturns
Competitors and Market Share
Key Competitors
- COOP
- MDT
Competitive Landscape
Utah Medical Products competes in niche segments with larger companies, but it maintains competitive advantages through specialization, innovation, and a reputation for quality.
Major Acquisitions
Femcare Ltd.
- Year: 2007
- Acquisition Price (USD millions): 2.4
- Strategic Rationale: Acquired the assets and manufacturing rights to certain products used in conjunction with uterine aspiration.
Growth Trajectory and Initiatives
Historical Growth: Utah Medical Products growth historically has been steady but not explosive, driven by niche product success and strategic acquisitions. Reference SEC filings for exact historical values.
Future Projections: Analyst estimates vary, but future growth is expected to be driven by expansion into new markets, innovative product development, and potential acquisitions. Analyst estimates are not directly available in this structured format.
Recent Initiatives: Recent strategic initiatives may include new product launches, geographic expansion efforts, or acquisitions of smaller companies.
Summary
Utah Medical Products is a niche player in the medical device industry focusing on women's and infant's health. It has a strong reputation for product quality and high profit margins, but it is more vulnerable to competition than larger, more diversified peers. Geographic revenue concentration is an area to watch. The company has a good track record of strategic acquisitions for growth.
Similar Companies
- COOP
- BWAY
- LEMO
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Financial News Articles
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market share estimates are approximate and may vary. Financial data is based on publicly available information and may be subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Utah Medical Products Inc
Exchange NASDAQ | Headquaters Midvale, UT, United States | ||
IPO Launch date 1999-03-08 | Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 155 | Website https://www.utahmed.com |
Full time employees 155 | Website https://www.utahmed.com |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.